Biotech

All Articles

Lundbeck slashes worth of $250M Abide buyout after pain setback

.Lundbeck is lowering guide worth of its $250 million Abide Therapeutics acquistion in reaction to s...

Real- Globe Information Satisfies Clinical Test Concept: Enhancing Methods and Website Assortment

.The integration of real-world information (RWD) in to procedure feasibility and website option has ...

Where are they today? Catching up with past Fierce 15 guest of honors

.At this year's Fierce Biotech Summit in Boston ma, our company caught up with innovators in the bio...

Merck buys preclinical DNA biotech for $1.3 B biobucks

.Merck &amp Co. is taking down $30 million ahead of time to buy Yale spinout Modifi Biosciences, a p...

Radiopharma Alpha-9 elevates $175M series C to money scientific press

.Alpha-9 Oncology has increased a $175 million series C round to bankroll its clinical-stage radioph...

Ocuphire to enhance right into gene therapy biotech using Opus acquistion

.Eye drug maker Ocuphire Pharma is acquiring gene treatment creator Piece Genetics in an all-stock p...

Roche culls hack prospect, rotates KRAS program in Q3 improve

.Roche's persistent cough plan has faltered to a standstill. The drugmaker, which axed the system af...

Merck- Gilead long-acting dental combo suppresses HIV for 48 weeks

.Gilead Sciences and also Merck &amp Co. have actually guided their once-weekly HIV combination trea...

Lykos takes FDA watch that MDMA authorization relies upon fresh trial

.Lykos Rehabs may possess lost three-quarters of its team back the FDA's rejection of its MDMA prosp...

Septerna organizes $158M IPO to money readouts for GPCR pipeline

.Septerna might be actually yet to reveal "any sort of meaningful medical records," however the biot...